India Glycols Reports Mixed Q2 Results with Revenue Decline but Stable Profitability
India Glycols Limited (IGL) released its Q2 FY2026 results, showing a 50.9% decrease in consolidated revenue to ₹2,412.40 crore. Despite this, the company maintained profitability with a consolidated profit after tax of ₹65.06 crore. Segment-wise, Bio-Fuel showed 62.9% growth, while other segments declined. The board approved raising up to ₹466.99 crore through equity share issuance at ₹915 per share.

*this image is generated using AI for illustrative purposes only.
India Glycols Limited (IGL) has released its financial results for the quarter ended September 30, 2025, revealing a mixed performance with a significant revenue decline but maintained profitability.
Revenue Decline
The company reported a consolidated revenue from operations of ₹2,412.40 crore for Q2 FY2026, marking a substantial decrease of 50.9% compared to ₹4,913.74 crore in the previous quarter. This sharp decline in revenue indicates potential challenges in the company's operational environment or market conditions.
Profitability Maintained
Despite the revenue drop, India Glycols managed to maintain its profitability. The company reported a consolidated profit after tax of ₹65.06 crore for Q2 FY2026, compared to ₹106.79 crore in the first half of FY2026. While this represents a decrease, it's worth noting that the company has remained profitable in a challenging quarter.
Segment Performance
India Glycols operates across multiple segments, with varying performances:
| Segment | Revenue (₹ crore) | YoY Change |
|---|---|---|
| Bio-based Specialities and Performance Chemicals | 288.33 | -22.0% |
| Potable Spirits | 1,657.82 | +14.0% |
| Ennature Biopharma | 43.44 | -28.7% |
| Bio-Fuel | 422.81 | +62.9% |
The Bio-Fuel segment showed significant growth, while other segments experienced declines compared to the same quarter last year.
Financial Position
As of September 30, 2025, India Glycols reported:
- Total assets of ₹6,157.24 crore
- Total equity of ₹2,393.63 crore
- Current liabilities of ₹2,025.22 crore
Capital Raising Initiative
The company's board has approved raising funds through the issuance of up to 51,03,765 equity shares at ₹915 per share, potentially bringing in an aggregate amount of up to ₹466.99 crore. This capital raise may be aimed at strengthening the company's financial position or funding future growth initiatives.
Conclusion
India Glycols continues to navigate a challenging business environment, as evidenced by the revenue decline. However, the company's ability to maintain profitability and its efforts to raise additional capital suggest a proactive approach to addressing market challenges. Investors and stakeholders may want to closely monitor the company's performance in the coming quarters to assess the effectiveness of its strategies in reversing the revenue decline while maintaining profitability.
Historical Stock Returns for India Glycols
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.44% | +3.71% | +8.86% | +21.33% | +78.86% | +644.88% |




































